Primary Site >> Stomach Cancer

Gene >> HAVCR2

  • 2010
  • 2011
  • 2013
  • 2014
  • 2015
  • 2016
  • 2017
  • 2018
Ref: Genetic variations and haplotypes in TIM-3 gene and the risk of gastric cancer.
PMID: 20811886
Ref: T-cell-mediated tumor immune surveillance and expression of B7 co-inhibitory molecules in cancers of the upper gastrointestinal tract.
PMID: 21717068
Ref: Decreased galectin-9 and increased Tim-3 expression are related to poor prognosis in gastric cancer.
PMID: 24339967
Ref: Role of downregulation of galectin-9 in the tumorigenesis of gastric cancer.
PMID: 24919464
Ref: [The number of myeloid-derived suppressor cells in the peripheral blood and tumor tissues in patients with gastric cancer and its clinical significance].
PMID: 25001941
Ref: The Clinical Significance of Abnormal Tim-3 Expression on NK Cells from Patients with Gastric Cancer.
PMID: 26214042
Ref: Expression of Tim-3 in gastric cancer tissue and its relationship with prognosis.
PMID: 26464703
Ref: Preferential Tim-3 expression on Treg and CD8(+) T cells, supported by tumor-associated macrophages, is associated with worse prognosis in gastric cancer.
PMID: 27648132
Ref: Upregulation of T-cell Immunoglobulin and Mucin-Domain Containing-3 (Tim-3) in Monocytes/Macrophages Associates with Gastric Cancer Progression.
PMID: 27911104
Ref: Tumor antigen-specific CD8(+) T cells are negatively regulated by PD-1 and Tim-3 in human gastric cancer.
PMID: 28110884
Ref: Tim-3 Up-regulation in Patients with Gastric Cancer and Peptic Ulcer Disease
PMID: 28441784
Ref: Association between Tim3 and Gal9 expression and gastric cancer prognosis.
PMID: 30106451
Ref: Co-inhibition of TIGIT, PD1, and Tim3 reverses dysfunction of Wilms tumor protein-1 (WT1)-specific CD8+ T lymphocytes after dendritic cell vaccination in gastric cancer.
PMID: 30210924